Fractional Flow Reserve Market Comprehensive Analysis and Future Estimations 2026
A fractional flow reserve device is used in cardiac catheterization to monitor pressure changes across coronary artery stenosis to assess whether the narrowing is impeding oxygen delivery to the heart muscle. A customized guidewire is used to assess blood pressure in a coronary artery during fractional flow reserve (FFR). During coronary angiography, a conventional diagnostic catheter is used to measure FFR.
Furthermore, the growth potential in developing nations, as well as the rising prevalence of cardiovascular disorders, would present further growth prospects for the Fractional Flow Reserve Market in the future years. Nonetheless, the technical constraints of intrusive FFR may provide additional challenges to the growth of the fractional flow reserve industry in the near future.
The increasing older population, the concomitant increase in the occurrences of coronary artery disease, and the cost-benefit are major factors projected to drive the Growth of The Fractional Flow Reserve Market during the forecast period. Furthermore, the appropriate reimbursement scenario, as well as the rising prevalence of coronary artery disease and high blood pressure, are some of the reasons that are expected to drive the expansion of the market for fractional flow reserve. However, one of the reasons expected to further restrict the growth of the market for fractional flow reserve in the timeframe period is interventional cardiologists' reluctance to use FFR.
Drivers of the Global Fractional Flow Reserve Market
Leading manufacturers are engaged in the production of goods for the treatment of coronary heart disease (CHD). For example, in May 2019, Phillips introduced Instant Wave Free Ratio (iFR), a modified version of the Fractional Flow Reserve Market. This improved version eliminates the need for adenosine, which is often utilized in FFR to induce hyperemia in patients. Furthermore, Heartflow introduced an FFR-embedded new cardiac CT scanner (FFRCT) in 2014, allowing patients to avoid the invasive testing method performed during the cardiac catheterization process. In addition, Opsens, Inc. launched "Optowire," a guidewire with optic sensing technology, in November 2019.
Comments
Post a Comment